These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20000078)

  • 1. [Main reasons for a need for retreatment of pulmonary tuberculosis in Armenia in the past 10 years].
    Adzhemian AA; Markarian NR; Mkrtchian MM
    Tuberk Biolezni Legkih; 2009; (10):37-40. PubMed ID: 20000078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outcomes of treatment in new cases of infiltrative pulmonary tuberculosis, prediction of the risk for its relapse].
    Grigor'eva EA; Kopylova IF
    Tuberk Biolezni Legkih; 2009; (9):16-9. PubMed ID: 19886011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
    Kameda K; Kawabata S; Masuda N
    Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncontrolled trial of sparfloxacin in retreatment of pulmonary tuberculosis.
    Rao S
    Respirology; 2004 Aug; 9(3):402-5. PubMed ID: 15363016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The current aspects of the recurrence of tuberculosis of the respiratory organs in adults].
    Gavrilenko VS; Khruleva TS
    Probl Tuberk; 1996; (4):2-4. PubMed ID: 9026797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis.
    Verver S; Warren RM; Beyers N; Richardson M; van der Spuy GD; Borgdorff MW; Enarson DA; Behr MA; van Helden PD
    Am J Respir Crit Care Med; 2005 Jun; 171(12):1430-5. PubMed ID: 15831840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficiency of treatment for recurrent tuberculosis and its influencing factors].
    Il'ina TIa; Zhangireev AA; Sidorenko OA
    Tuberk Biolezni Legkih; 2009; (12):38-42. PubMed ID: 20099386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment and outcomes of disseminated pulmonary tuberculosis].
    Rzhavskov IV; Lishchinskii AB; Znosenko VA
    Probl Tuberk; 1997; (1):40-1. PubMed ID: 9162924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line chemotherapy in the retreatment of bacteriological relapses of pulmonary tuberculosis following a shortcourse regimen.
    Lancet; 1976 Jan; 1(7952):162-3. PubMed ID: 54680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB.
    Rich ML; Socci AR; Mitnick CD; Nardell EA; Becerra MC; Bonilla C; Bayona J; Seung KJ; Furin J; Farmer PE; Mukherjee JS
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):290-6. PubMed ID: 16562709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study.
    Sanchez-Padilla E; Marquer C; Kalon S; Qayyum S; Hayrapetyan A; Varaine F; Bastard M; Bonnet M
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):160-7. PubMed ID: 24429307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary drug resistance in Mycobacterium tuberculosis among patients with pulmonary tuberculosis and its impact on permanent disability in the Volgograd region].
    Borzenko AS; gagarina SG; Samoĭlova IV; Kalushenina AA
    Probl Tuberk Bolezn Legk; 2007; (12):28-30. PubMed ID: 18326212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcomes of pulmonary tuberculosis in patients without bacterial isolation (according to sputum microscopy data)].
    Kopylova IF; Lomova LA
    Tuberk Biolezni Legkih; 2009; (9):12-5. PubMed ID: 19882856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
    Sevim T; Ataç G; Güngör G; Törün I; Aksoy E; Gemci ; Tahaoglu K
    Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The causes of a relapse in pulmonary tuberculosis in patients with a history of focal forms of the disease].
    Petrenko VM; Turchenko LV; Bobarykin VS
    Vrach Delo; 1991 Mar; (3):37-40. PubMed ID: 2042345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of chemotherapy for relapses from respiratory tuberculosis.
    Groth-Petersen B
    Scand J Respir Dis; 1976; 57(3):108-12. PubMed ID: 981998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.